EUVIMEDEUVIMED entdecken
Crossref

Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors

Geoffrey Bostany, Yanjun Chen, Liton Francisco iD, Chen Dai, Qingrui Meng, Jessica Sparks iD, Min Sessions, Lisle Nabell iD, Erica Stringer-Reasor iD, Katia Khoury iD, Carrie Lenneman, Kimberly Keene iD und 3 weitere

Journal of Clinical Oncology · 2025

DOI: 10.1200/jco.23.01779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2025. Verfasst von Geoffrey Bostany und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham (UAB) Heersink School of Medicine (SOM), Birmingham, AL. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Cardiac dysfunction is the leading cause of mortality among 10-year breast cancer survivors. Limited information regarding long-term risks of cardiac dysfunction after cardiotoxic therapy (anthracyclines, trastuzumab/pertuzumab, radiation) has precluded development of surveillance guidelines for the survivors. METHODS Patients with breast cancer who completed cardiotoxic therapy underwent echocardiographic screening every 2 years. New-onset cardiac dysfunction was defined as left ventricular ejection fraction (LVEF)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCancer SurvivorsHumansFemaleMiddle AgedAdultAgedAged, 80 and overCardiotoxicityAnthracyclinesYoung AdultEchocardiographyTrastuzumabRisk FactorsHeart Disease Risk FactorsHeart Diseases

Substanzen

AnthracyclinesTrastuzumab

Autor:innen und Institutionen

  • Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham (UAB) Heersink School of Medicine (SOM), Birmingham, AL.
  • Division of Hematology/Oncology, UAB, Birmingham, AL.
  • Division of Cardiology, UAB, Birmingham, AL.
  • Division of Radiation Oncology, UAB, Birmingham, AL.
  • Department of Pediatric Oncology, City of Hope, Duarte, CA.
  • Division of Pediatric Hematology/Oncology, UAB, Birmingham, AL.

ORCID-Profile: Liton Francisco, Jessica Sparks, Lisle Nabell, Erica Stringer-Reasor, Katia Khoury, Kimberly Keene, Saro Armenian, Wendy Landier, Smita Bhatia

Zitieren

APA

Bostany, G., Chen, Y., Francisco, L., Dai, C., Meng, Q., Sparks, J., Sessions, M., Nabell, L., Stringer-Reasor, E., Khoury, K., Lenneman, C., Keene, K., Armenian, S., Landier, W., & Bhatia, S. (2025). Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.01779

Vancouver

Bostany G, Chen Y, Francisco L, Dai C, Meng Q, Sparks J, et al. Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors. Journal of Clinical Oncology. 2025. doi:10.1200/jco.23.01779

BibTeX
@article{Bostany2025,
  author = {Bostany, Geoffrey and Chen, Yanjun and Francisco, Liton and Dai, Chen and Meng, Qingrui and Sparks, Jessica and Sessions, Min and Nabell, Lisle and Stringer-Reasor, Erica and Khoury, Katia and Lenneman, Carrie and Keene, Kimberly and Armenian, Saro and Landier, Wendy and Bhatia, Smita},
  title = {Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1200/jco.23.01779}
}
Kostenlos starten →